Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial

2006 ◽  
Vol 114 (s185) ◽  
pp. 3-7 ◽  
Author(s):  
D. L. Sparks ◽  
D. J. Connor ◽  
M. N. Sabbagh ◽  
R. B. Petersen ◽  
J. Lopez ◽  
...  
2006 ◽  
Vol 2 ◽  
pp. S179-S179
Author(s):  
Jonathan M. Schott ◽  
Basil H. Ridha ◽  
Sebastian J. Crutch ◽  
Elizabeth K. Warrington ◽  
Martin N. Rossor ◽  
...  

2010 ◽  
Vol 25 (5) ◽  
pp. 511-518 ◽  
Author(s):  
Dylan G. Harwood ◽  
Ari Kalechstein ◽  
Warren W. Barker ◽  
Silvia Strauman ◽  
Peter St. George-Hyslop ◽  
...  

1999 ◽  
Vol 843 (1-2) ◽  
pp. 87-94 ◽  
Author(s):  
Uwe Beffert ◽  
Jeffrey S Cohn ◽  
Caroline Petit-Turcotte ◽  
Michel Tremblay ◽  
Nicole Aumont ◽  
...  

1996 ◽  
Vol 165 (2) ◽  
pp. 77-80 ◽  
Author(s):  
Victoria A Fabian ◽  
Thomas M Jones ◽  
Stephen D Wilton ◽  
Joanne E Dench ◽  
Mark R Davis ◽  
...  

1999 ◽  
Vol 27 (5-6) ◽  
pp. 544-553 ◽  
Author(s):  
Charles Ramassamy ◽  
Diana Averill ◽  
Uwe Beffert ◽  
Stephane Bastianetto ◽  
Louise Theroux ◽  
...  

1998 ◽  
Vol 338 (8) ◽  
pp. 506-511 ◽  
Author(s):  
Richard Mayeux ◽  
Ann M. Saunders ◽  
Steven Shea ◽  
Suzanne Mirra ◽  
Denis Evans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document